Alexey Matyushevsky serves as the Executive Director of the Ассоциация специалистов медицинских исследований "ДОКАЗАТЕЛЬСТВО," where he plays a pivotal role in advancing clinical research standards and practices in Russia. With a robust background as the Head of the Russian Office for CONFIDENCE Pharmaceutical Research, LLC,...
Alexey Matyushevsky serves as the Executive Director of the Ассоциация специалистов медицинских исследований "ДОКАЗАТЕЛЬСТВО," where he plays a pivotal role in advancing clinical research standards and practices in Russia. With a robust background as the Head of the Russian Office for CONFIDENCE Pharmaceutical Research, LLC, Alexey brings a wealth of expertise in clinical trial management and regulatory affairs. His dual qualifications as an MD, Cardiologist, and Clinical Pharmacologist uniquely position him to bridge the gap between clinical practice and research, ensuring that studies are not only scientifically sound but also ethically conducted.
In his current role, Alexey leads initiatives focused on Good Clinical Practice (GCP) training for professionals in research organizations, pharmaceutical companies, and investigator sites. His comprehensive training programs, which include GCP and investigator school modules, are designed to enhance the skills of clinical researchers and ensure compliance with international standards such as ICH-GCP. Additionally, he provides consulting services to participants in clinical trials, guiding them through the complexities of study design and execution.
Alexey is also actively involved in auditing research centers and organizations, ensuring that they adhere to the highest standards of quality and regulatory compliance. His expertise spans various therapeutic areas, with a particular focus on oncology and pharmacovigilance, making him a sought-after consultant in the field. By fostering collaboration among stakeholders and promoting best practices in clinical research, Alexey Matyushevsky is dedicated to enhancing the integrity and efficacy of clinical trials in Russia, ultimately contributing to the advancement of medical science and patient care.
